Tirzepatide, sold as Mounjaro and Zepbound, is our most potent weight-loss drug, but it can have an even greater effect when ...

Newly presented research suggests that moving from a GLP-1 injectable to a pill continues weight loss. Doctors aren’t shocked ...

Researchers found the spread of cancer was lower among six cancer types in patients taking GLP-1 drugs—a statistically ...

Ribupatide injection (KAI-9531) aims to address critical need for greater weight loss, especially for people living with a BMI of 35 kg/m² or ...

From vaccines to gene therapies, mRNA medicines often rely on tiny fat-based particles called lipid nanoparticles, or LNPs, ...

Kailera Therapeutics and Hengrui Pharma’s weekly injection showed benefits beyond weight loss in a mid-stage trial, leading ...

You may have seen headlines about the new GLP-1 pill and wondered if it’s time to retire your weekly shot. The idea is appealing: no refrigeration, no injection day, no sharps container under the sink ...

Kailera Therapeutics, Inc. announced Phase 1 data for ribupatide injection, a GLP-1/GIP receptor dual agonist currently advancing through global Phase 3 clinical trials, presented at the 62nd Annual ...

Add Yahoo as a preferred source to see more of our stories on Google. If you go to a med spa for GLP-1 injections, you may want to start asking questions about where those drugs are actually coming ...

South Korean health authorities have strengthened guidelines for GLP-1 (glucagon-like peptide-1) obesity drugs — widely known ...

Mistaking units for milligrams or doubling up after a missed week can turn a routine weight loss injection into a medical emergency. Doctors share the red flags to watch for.